Association between social vulnerability index and admission urgency for transcatheter aortic valve replacement.

Aortic stenosis Emergency Healthcare delivery Social determinants of health Social vulnerability index Valve replacement Valve surgery

Journal

American heart journal plus : cardiology research and practice
ISSN: 2666-6022
Titre abrégé: Am Heart J Plus
Pays: United States
ID NLM: 101779333

Informations de publication

Date de publication:
Mar 2024
Historique:
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 12 3 2024
Statut: ppublish

Résumé

Transcatheter aortic valve replacement (TAVR) are not offered equitably to vulnerable population groups. Adequate levels of insurance may narrow gaps among patients with higher social vulnerability index (SVI). Among a national population of individuals with commercial or Medicare insurance, we sought to determine whether SVI was associated with urgency of receipt of TAVR for aortic stenosis. Using Optum's de-identified Clinformatics Data Mart Database (CDM), we identified admissions for TAVR with aortic stenosis between January 2018 and March 2022. Admission urgency was identified by CDM claims codes. SVI was cross-referenced to patient zip codes and grouped into quintiles. Generalized linear mixed effects models were used to predict the probability of a TAVR admission being urgent based on SVI quintiles, adjusting for patient and hospital-level covariates. Among 6680 admissions for TAVR [median age 80 years (interquartile range 75-85), 43.9 % female], 8.5 % ( Among commercial or Medicare beneficiaries with aortic stenosis, SVI was not associated with admission urgency for TAVR. To clarify whether cardiovascular care delivery is improved across SVI with higher paying beneficiaries, future investigation should identify whether relationships between SVI and TAVR urgency vary for Medicaid beneficiaries compared to commercial beneficiaries.

Sections du résumé

Background UNASSIGNED
Transcatheter aortic valve replacement (TAVR) are not offered equitably to vulnerable population groups. Adequate levels of insurance may narrow gaps among patients with higher social vulnerability index (SVI). Among a national population of individuals with commercial or Medicare insurance, we sought to determine whether SVI was associated with urgency of receipt of TAVR for aortic stenosis.
Methods and results UNASSIGNED
Using Optum's de-identified Clinformatics Data Mart Database (CDM), we identified admissions for TAVR with aortic stenosis between January 2018 and March 2022. Admission urgency was identified by CDM claims codes. SVI was cross-referenced to patient zip codes and grouped into quintiles. Generalized linear mixed effects models were used to predict the probability of a TAVR admission being urgent based on SVI quintiles, adjusting for patient and hospital-level covariates.
Results UNASSIGNED
Among 6680 admissions for TAVR [median age 80 years (interquartile range 75-85), 43.9 % female], 8.5 % (
Conclusions UNASSIGNED
Among commercial or Medicare beneficiaries with aortic stenosis, SVI was not associated with admission urgency for TAVR. To clarify whether cardiovascular care delivery is improved across SVI with higher paying beneficiaries, future investigation should identify whether relationships between SVI and TAVR urgency vary for Medicaid beneficiaries compared to commercial beneficiaries.

Identifiants

pubmed: 38469116
doi: 10.1016/j.ahjo.2024.100370
pmc: PMC10927260
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Dr. Khadijah Breathett is an Editorial Board Member for American Heart Journal and was not involved in the editorial review or the decision to publish this article.

Auteurs

Ikeoluwapo Kendra Bolakale-Rufai (IK)

Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, IN, United States of America.

Alexander Shinnerl (A)

School of Medicine, Indiana University, Indianapolis, IN, United States of America.

Shannon M Knapp (SM)

Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, IN, United States of America.

Amber E Johnson (AE)

Division of Cardiovascular Medicine, University of Chicago, Chicago, IL, United States of America.

Selma Mohammed (S)

Division of Cardiovascular Medicine, Creighton University, Omaha, NE, United States of America.

LaPrincess Brewer (L)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America.

Asad Torabi (A)

Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, IN, United States of America.

Daniel Addison (D)

Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, United States of America.

Sula Mazimba (S)

Division of Cardiovascular Medicine, University of Virginia, Charlottesville and AdventHealth, Orlando, FL, United States of America.

Khadijah Breathett (K)

Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, IN, United States of America.

Classifications MeSH